More about

Arthritis

News
September 16, 2019
4 min watch
Save

VIDEO: High incidence of arthritis seen at the metatarsal head sesamoid articulation

VIDEO: High incidence of arthritis seen at the metatarsal head sesamoid articulation

CHICAGO — At the American Orthopaedic Foot and Ankle Society Annual Meeting, Steven M. Raikin, MD, discussed a study that looked at degenerative changes at the metatarsal head sesamoid articulation seen during surgery for hallux valgus correction. He said there was a high incidence of arthritis (87%) at the metatarsal head sesamoid articulation.

News
September 11, 2019
1 min read
Save

Suture button suspensionplasty had superior outcomes vs other techniques

LAS VEGAS — Results presented at the American Society for Surgery of the Hand Annual Meeting showed thumb carpometacarpal Mini TightRope (Arthrex) suture button suspensionplasty following trapeziectomy led to less subsidence and better functional outcomes compared with flexor carpi radialis and abductor pollicis longus suspensionplasties.

News
August 19, 2019
2 min read
Save

Pediatric rheumatologist shortage a serious barrier to care for children

Pediatric rheumatologist shortage a serious barrier to care for children

ORLANDO — There are less then 350 pediatric rheumatologists currently practicing in the United States, representing a substantial barrier to care for the 300,000 children with arthritis, 30,000 with systemic lupus erythematosus and 3,000 with juvenile dermatomyositis across the country, according to Cathy Patty-Resk, MSN, RN-BC, CPNP-BC, president-elect of the Rheumatology Nurses Society.

News
August 16, 2019
2 min read
Save

FDA approves Rinvoq for methotrexate-refractory RA

FDA approves Rinvoq for methotrexate-refractory RA

The FDA has approved upadacitinib, a 15-mg, once-daily oral JAK inhibitor, for the treatment of moderate-to-severe rheumatoid arthritis among patients who have had an inadequate response to methotrexate, according to an AbbVie press release.

News
August 16, 2019
7 min read
Save

Arthritis drug market rattles as upadacitinib wins race to FDA approval

Arthritis drug market rattles as upadacitinib wins race to FDA approval

In a landmark FDA approval, AbbVie’s upadacitinib has won the race to enter the drug market as the third JAK inhibitor approved for the treatment of moderate-to-severe rheumatoid arthritis, with the drug expected to be available in the United States within the month.

News
August 09, 2019
2 min read
Save

Sexual dysfunction more common in women with RA, PsA

Sexual dysfunction more common in women with RA, PsA

ORLANDO — Decreased sexual functioning is more common among female patients with rheumatoid arthritis and psoriatic arthritis, which should prompt early screenings for these patient populations, according to study findings presented at the Rheumatology Nurses Society Annual Conference.

News
August 09, 2019
3 min read
Save

Providers, patients wary to navigate 'confused system' of CBD laws, labels

Providers, patients wary to navigate 'confused system' of CBD laws, labels

ORLANDO — Physicians, nurses and patients must be vigilant when attempting to navigate the often contradictory, seemingly “confused system” of laws and labels associated with medical cannabis and cannabidiol – more widely known as CBD – according to a presenter at the 2019 Rheumatology Nurses Society Annual Meeting.

View more